Stran & Company, Inc. (SWAG) - 10-K Summary for Fiscal Year Ended December 31, 2024
Business Context and Reporting Period
Company: Stran & Company, Inc.
Reporting Period: Fiscal Year Ended December 31, 2024
Business Overview: Stran is an outsourced marketing solutions provider specializing in promotional products, loyalty incentive programs, and branded merchandise. The company operates through two segments: the core "Stran" segment and the newly acquired "Stran Loyalty Solutions" (SLS) segment, which focuses on casino continuity and loyalty programs following the August 2024 acquisition of Gander Group assets.
Market Position: Ranked 20th on PPAI's Top 100 Distributors list and 27th on ASI's Top 40 Distributors list for 2024.
Key Financial Metrics
| Metric (in thousands) | 2024 | 2023 |
|---|---|---|
| Total Sales | $82,654 | $76,000 |
| Gross Profit | $25,813 | $24,852 |
| Gross Margin | 31.2% | 32.7% |
| Operating Loss | $(4,894) | $(1,268) |
| Net Loss | $(4,140) | $(385) |
| Cash and Cash Equivalents | $9,358 | $8,059 |
| Total Assets | $55,148 | $49,036 |
| Total Stockholders' Equity | $31,641 | $35,650 |
| Operating Cash Flow | $2,760 | $(2,550) |
Debt & Liquidity: The company's $7.0 million revolving line of credit with Salem Five Cents Savings Bank was terminated effective August 26, 2024, with no funds drawn at the time of termination. As of December 31, 2024, the company held approximately $9.4 million in cash and $8.9 million in investments.
Material Changes vs. Prior Period
- Revenue Growth: Total sales increased 8.8% year-over-year to $82.7 million. This growth was driven by the acquisition of Gander Group assets (SLS segment) which contributed $9.9 million in revenue, partially offset by a 4.3% decline in the core Stran segment due to lower spending from existing and new clients.
- Margin Compression: Gross margin decreased from 32.7% to 31.2%. The SLS segment operates at a lower gross margin (20.8%) compared to the Stran segment (32.7%), diluting the overall margin.
- Operating Expenses: Operating expenses increased 17.6% to $30.7 million. Increases were attributed to the integration of Gander Group, implementation of the NetSuite ERP system, and legal/accounting fees related to the restatement of historical financial statements.
- Net Loss Expansion: Net loss widened significantly to $4.1 million from $0.4 million, primarily due to higher operating expenses and the lower-margin mix from the new acquisition.
- Segment Addition: The SLS segment was established in August 2024 following the Gander Group acquisition, representing 12% of total revenue.
Guidance, Outlook, Risks, and Unusual Items
Management Commentary & Outlook:
- Technology: The company launched its new Oracle/NetSuite ERP system in the first half of 2025 to improve data organization and operational efficiency.
- Strategy: Focus remains on converting transactional customers to program clients, expanding sales forces, and pursuing selective acquisitions in the southern and western U.S.
- Restatement: The company restated financial statements for fiscal years 2022 and 2023 due to material weaknesses in internal controls. This process has consumed significant management resources and legal fees.
- Internal Control Weaknesses: Management identified material weaknesses in internal controls over financial reporting as of December 31, 2024, including deficiencies in complex accounting transactions, income tax provisions, and IT general controls. Remediation is underway but not yet complete.
- Nasdaq Compliance: The company faced delisting risks regarding filing requirements, annual meeting rules, and minimum bid price. As of the filing date, the company had regained compliance with filing and bid price rules but must hold its 2024 annual meeting to fully resolve the Annual Meeting Rule deficiency.
- Customer Concentration: The top 10 customers accounted for 38.1% of revenue in 2024 (down from 46.1% in 2023). The largest single customer represented 8.4% of revenue.
- Trade & Supply Chain: Risks include tariffs, supply chain disruptions, and raw material cost inflation.
- Goodwill Impairment: No goodwill impairment was recorded in 2024. A $0.81 million impairment was recorded in 2023.
- Related Party Transactions: Significant receivables exist from Innovative Genetics (affiliated with a director), totaling $573,000 as of year-end, with accrued interest for past-due payments.
Key Facts for Investor Verification
- Restatement Impact: Verify the specific adjustments made to the 2022 and 2023 financial statements and the status of the remediation plan for internal control weaknesses.
- Nasdaq Listing Status: Confirm the scheduling and successful completion of the 2024 annual shareholder meeting to ensure continued compliance with Nasdaq Listing Rule 5620(a).
- Debt Facilities: Confirm the status of financing arrangements following the termination of the Salem Five Cents line of credit and the company's ability to fund operations without this facility.
- Related Party Receivables: Assess the collectability of the $573,000 receivable from Innovative Genetics and the associated interest accruals.
- ERP Implementation: Monitor the rollout of the NetSuite ERP system and its impact on operational costs and efficiency in 2025.